Clene Inc. Presentation of RESCUE-ALS Topline Clinical Trial Results Transcript
Presentation of RESCUE-ALS Topline Clinical Trial Results
Nov 02, 2021 / 12:00PM GMT
=====================
Corporate Participants
=====================
* John Woolford
Westwicke - Managing Director
* Rob Etherington
Clene, Inc. - Chairman and CEO
* Steve Vucic
University of Sydney - Northcott Chair of Neurology
* Robert Glanzman
Clene, Inc. - CMO
* Matthew Kiernan
University of Sydney - Bushell Chair of Neurology
=====================
Conference Call Participants
=====================
* Charles Duncan
Cantor Fitzgerald - Analyst
* Leland Gershell
Oppenheimer - Analyst
* Elemer Piros
Roth Capital Partners - Analyst
* Naz Rahman
Maxim Group - Analyst
* Bruce Jackson
The Benchmark Company - Analyst
=====================
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |